Contineum Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Contineum Therapeutics, Inc. has filed 189 SEC EDGAR filings since 13 Dec 2023

SEC filing history

Showing 101-125 of 189 matching filings.

Per page
25
Current page
5
S-3 File 333-287275

FORM S-3

Filing date
14 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-42001

ARS

Filing date
29 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-42001

FORM DEFA14A

Filing date
29 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-42001

FORM DEF 14A

Filing date
29 Apr 2025
Reporting date
26 Jun 2025
Next action
Verify source filing
4

FORM 4

Filing date
28 Apr 2025
Reporting date
28 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
28 Apr 2025
Reporting date
28 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
17 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-285595

FORM S-8

Filing date
06 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94496

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-94496

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2025
Reporting date
31 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2025
Reporting date
31 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2025
Reporting date
31 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2025
Reporting date
31 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jan 2025
Reporting date
31 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Nov 2024
Reporting date
25 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-42001

144 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .